All Articles by Author:

lbeveridge

Myeloid TLR4 Signaling Promotes Post-Injury Withdrawal Resolution of Murine Liver Fibrosis

[iScience] Single-cell transcriptome analysis of hepatic CD11b+ cells, main producers of matrix metalloproteinases, revealed a prominent cluster of restorative Tlr4-expressing Ly6c2-low myeloid cells.

Stiff Matrix Induces Exosome Secretion to Promote Tumor Growth

[Nature Cell Biology] The authors delineated a molecular pathway that links stiff ECM to activation of Akt, which in turn promoted GTP loading to Rab8 that drove' exosome secretion.

Arrowhead Pharmaceuticals Gains Full Rights to NASH Candidate ARO-PNPLA3 with Promising Phase I Results

[Arrowhead Pharmaceuticals, Inc.] Arrowhead Pharmaceuticals, Inc. announced that it has gained rights to ARO-PNPLA3, formerly called JNJ-75220795, which was part of a 2018 research collaboration and option agreement between Arrowhead and Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Kupffer-Cell-Derived IL-6 Is Repurposed for Hepatocyte Dedifferentiation via Activating Progenitor Genes from Injury-Specific Enhancers

[Cell Stem Cell] Scientists uncovered that periportal-specific liver progenitor-like cell formation was initiated by regionally activated Kupffer cells but not peripheral monocyte-derived macrophages.

Bioengineered Liver Crosslinked with Nano-Graphene Oxide Enables Efficient Liver Regeneration via MMP Suppression and Immunomodulation

[Nature Communications] Researchers demonstrated that scaffolds crosslinked with nano-graphene oxide show high resistance to enzymatic degradation via direct inhibition of matrix metalloproteinase activity and increased mechanical rigidity.

The Genetic Background Shapes the Susceptibility to Mitochondrial Dysfunction and NASH Progression

[Journal of Experimental Medicine] Investigators tested the susceptibility of seven mouse strains to develop non-alcoholic steatohepatitis (NASH). The severity of the clinical phenotypes observed varied widely across strains.

Popular

Single-Cell Analysis of Anti-BCMA CAR T Cell Therapy in Patients with Central Nervous System Autoimmunity

[Science Immunology] Investigators performed single-cell multi-omics sequencing of paired cerebrospinal fluid and blood samples from patients with neuromyelitis optica spectrum disorder treated with anti–B cell maturation antigen (BCMA) CAR T cells.

Unveiling the Proteome-Wide Autoreactome Enables Enhanced Evaluation of Emerging CAR-T Therapies in Autoimmunity

[European Journal Of Clinical Investigation] Researchers leveraged advances in programmable-phage immunoprecipitation methodology to explore the modulation, or lack thereof, of autoantibody profiles, proteome-wide, in both health and disease.

Arming Vδ2 T Cells With Chimeric Antigen Receptors to Combat Cancer

[Clinical Cancer Research] Following a comprehensive overview of γδ T cell biology and innovative CAR engineering strategies, investigators discuss the clinical potential of Vδ2 CAR-T cells to overcome the current limitations of immunotherapy in solid tumors.